Summary
Overview
Work History
Education
Skills
Beyondscience
Internationalconferencepresentations
Awards
Publications
Continuingeducation
Timeline
Generic

Mahmut Mijit, PhD

Doylestown,USA

Summary

Clinical Pharmacist and instructor of Physiology and Pharmacology in Medical Education. PhD in Cell biology and Molecular Medicine, Pharmacology, Immuno-Oncology. Over 5 years of expertise in Oncology and anti-inflammatory therapeutic areas (TAs), human solid tumors (PDAC, liver cancer), Autoimmune and Inflammation (AI), Orphan diseases. Skilled at presenting and articulating complex scientific subjects to HCPs/KOLs, C-suite executives, and patients, delivering measurable medical insights in the US and ex-US (China & EU). Expert in scientific writing, slide-deck review and editing, abstract and manuscript submission. Strong publication record, with 7 first-authored and 13 co-authored research articles, 10 presentations at international congresses, symposia. A quick learner with high emotional intelligence, skilled at transferring scientific knowledge, clinical insights, and communication expertise into new TAs.

Overview

12
12
years of professional experience

Work History

Scientist II, Autoimmune & Inflammation

IGM BIOSCIENCE
01.2023 - 10.2024
  • Led IGM Bio & Sanofi collaborated projects developing immune checkpoint inhibitors, allergy-inflammation & skin inflammation (atopic dermatitis)-relevant TAs
  • TCEs (CD3 x CD38), (CD3 x CD20)-IND filings & patent applications, and ex-US clinical trials in AI (SLE, RA, MG) diseases and/or oncology (multiple myeloma)
  • Analyzed early-stage trial results along with Clinical Biomarker Working Group and provided strategic insights to guide subsequent trial phases and inform key decision-making
  • Supported medical affairs representation and attend global international conferences, recent data disclosure, gathering competitive intelligence, dissemination of subject-matter insights

Postdoctoral Researcher

Indiana University-Purdue University
11.2020 - 01.2023
  • Initiated IND and Phase-1 clinical trials for IBD, human solid tumors (PDAC, prostate, liver cancer), advancing the pipelines of Ocuphire and Apexian pharmaceuticals
  • Clinical research support of APX3330 (Phase-III) in diabetic retinopathy (DR) and eye-inflammation, explored ocular indications, such as dry-eye, DME
  • Fostering successful collaborations between academic institutions and industry partners, engage in high-level scientific communication with industry board members, CSO, CMO and TLs

Scientist, R&D

Dompe` Pharmaceuticals
11.2019 - 11.2020
  • Explored MoA studies of Ladarixin (Phase-II), Reparaxin (Phase III) an inhibitor CXCR1 and CXCR2 in human AI diseases (T1D), and lung inflammation, respectively
  • Supporting clinical research of Oxervate, the FDA-approved first drug to treat neurotrophic keratitis (NK) and exploring alternative therapeutic areas
  • Coordinating global (EU-China) scientific collaboration with clinicians, CROs and developing strategies for market access in China
  • Project management with meeting planning, delivering minutes and presentation of project updates with global cross-functional team

Instructor

Xinjiang College of Science & Technology
05.2016 - 05.2017
  • Delivered lectures on physiology and pharmacology to med-students in Mandarin and English
  • Designed and implemented PBL & clinical case studies, maintained a 90% student success rate

Clinical pharmacist

Xinjiang Medical University Hospital
09.2012 - 05.2016
  • Patient enrollment in clinical trials, collection and processing of clinical samples in clinical laboratories, following ICH-GCP guidelines and applicable local regulations
  • Established relationships with local HCPs, compliance with China’s FDA regulatory guidelines
  • Presenting scientific data in Mandarin and English within the Global Medical Communications working group across multi-countries environments

Education

Ph.D. - Cell biology and Molecular Medicine

University of Teramo
01.2020

M.Sc. - Pharmacology

Xinjiang Medical University
01.2016

B.Sc. - Pharmacy/Medicine

Xinjiang Medical University
01.2013

Skills

  • Competent and well-versed in Windows OS, MacOS, and Microsoft Office Suite, Biorender
  • Proficient in Bioinformatics, Artificial intelligence (AI) statistical digital platforms, Veeva vault
  • Master in navigating global database, The US Clinical trial entry, ex-US (China & EU) entry

Beyondscience

  • Tennis instructor: Applied extensive tennis experience to coach advanced players.
  • Pickleball Coach – Bucks County Retirement Center as community services.
  • Volunteering at Bucks Country Shelter & Support the Homeless.

Internationalconferencepresentations

  • Ref-1 redox activity modulates canonical Wnt signaling in human retinal endothelial cells., ARVO, Seattle, 2024
  • Therapeutic Potential of Imvotamab, a CD20-Targeted Bispecific IgM T Cell Engager, for the Treatment of Refractory Autoimmune Disease Patients., ACR, San Diego, CA, 2023
  • Inhibition of Ref-1/APE1 redox activity with APX3330 enhances Ref-1/APE1 protein unfolded conformation in human PDAC cells., AACR, New Orleans, USA, 2022
  • Activation of Integrated Stress Response (ISR) pathways in response to Ref-1 inhibition human pancreatic cancer and its tumor microenvironment (TMEs)., SfRBM, Orlando, USA, 2022
  • SIRT1-mediated cytoprotective effects of RSV against HG stressed HUVECs., FEBS3+ LS2 Annual Meeting, Zurich, Switzerland, 2020
  • Sirt1 is essential for beneficial effect of resveratrol on hyperglycemia-induced endothelial dysfunction., General Assembly and Annual Conference of Marie Curie Alumni Association (MCAA), Vienna, Austria, 2019
  • SIRT1 activator resveratrol protects HUVECs from high glucose-dependent Redox and glycative imbalances., SfRBM, Las Vegas, USA, 2019
  • Protective Effect of 1950 MHz Electromagnetic Field in Human Neuroblastoma Cells Challenged with Menadione., 64th GEI Conference, L`Aquila, Italy, 2018
  • Studies of malignant tumors as abnormal savda syndrome in traditional Uyghur medicine: identification of common protein markers and potential therapeutic targets of the prescriptions., 8th International Biophysics Congress (IUPAB), Brisbane, Australia, 2014

Awards

  • Marie Skłodowska-Curie Action doctoral full scholarship, European Union (2017-2020)
  • Melvin and Bren Simon Comprehensive Cancer Center Travel award, USA (2022)
  • Best Poster Presentation Award, Abruzzo regional conference, Italy (2017)
  • Top 10 Outstanding Scholar Award, Xinjiang Medical University, China (2013)
  • American Association of Cancer Research (AACR) membership (2021-Now)
  • Society For Redox Biology and Medicine (SfRBM) Membership (2019-Now)
  • Italian Society of Developmental and Cell Biology (GEI) Member (2017-Now)
  • Marie Skłodowska-Curie Alumni Association Membership (2017-Now)

Publications

  • In vitro and In vivo evidence demonstrating chronic absence of Ref-1 Cysteine 65 impacts Ref-1 folding configuration, redox signaling, proliferation and metastasis in pancreatic cancer., Redox Biology, 2024, 38056311
  • Activation of Integrated Stress Response (ISR) pathways in response to APE1/Ref-1 inhibition human pancreatic cancer and its tumor microenvironment (TMEs)., Frontiers in Medicine, 2023, 37181357
  • Identification of Novel Pathways Regulated by APE1/Ref-1 in Human Retinal Endothelial Cells., Int J Mol Sci., 2023, 36674619
  • RelA is an essential target for enhancing cellular responses to the DNA repair/Ref-1 redox signaling protein and restoring perturbated cellular redox homeostasis in mouse PDAC cells., Frontiers in Oncology., 2022, 35402225
  • APE1/Ref-1 - One Target with Multiple Indications: Emerging Aspects and New Directions., J Cell Signal., 2021, 34557865
  • Role of p53 in the regulation of cellular senescence., Journal of Biomolecules, 2020, 3218271
  • APE1/Ref-1 as a Novel Target for Retinal Diseases., J Cell Signal., 2021, 3432687
  • Resveratrol effects on SIRT1-SIRT3-SOD2 axis in high-glucose-challenged HUVECs., In Free Radical Biology and Medicine, 2021
  • SIRT1- dependent up-regulation of antiglycative defense in HUVECs is essential for resveratrol protection against high glucose stress., Antioxidants., 2019, 31480513
  • Role of Mitochondria in the Oxidative Stress Induced by Electromagnetic Fields: Focus on Reproductive Systems., Oxid Med Cell Longev., 2018, 30533171
  • Differential integrative omic analysis for mechanism insights and biomarker discovery of abnormal Savda syndrome and its unique Munziq prescription., Sci Rep., 2016, 27296761
  • Metabolic differentiation, and classification of abnormal Savda Munziq's pharmacodynamics role on rat models with different diseases by nuclear magnetic resonance-based metabolomics., Pharmacogn Mag., 2015, 26600713

Continuingeducation

  • Completed multiple comprehensive MSL training workshops, covering aspects of the product life cycle today to day-to-day MSL activities, and passed the course with 100%.
  • Clinical Trials: Good Clinical Practice Specialization (Novartis)
  • FDA Clinical Investigator Training Course (CITC)
  • Regulation of Cell & Gene Therapy Products for Clinical Trials
  • Pre Pre-IND and Pre-IND Interactions for Cell and Gene Therapy Products (FDA)

Timeline

Scientist II, Autoimmune & Inflammation

IGM BIOSCIENCE
01.2023 - 10.2024

Postdoctoral Researcher

Indiana University-Purdue University
11.2020 - 01.2023

Scientist, R&D

Dompe` Pharmaceuticals
11.2019 - 11.2020

Instructor

Xinjiang College of Science & Technology
05.2016 - 05.2017

Clinical pharmacist

Xinjiang Medical University Hospital
09.2012 - 05.2016

Ph.D. - Cell biology and Molecular Medicine

University of Teramo

M.Sc. - Pharmacology

Xinjiang Medical University

B.Sc. - Pharmacy/Medicine

Xinjiang Medical University
Mahmut Mijit, PhD